As of 2026-05-12, the EV/EBITDA ratio of Corcept Therapeutics Inc (CORT) is -789.79. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CORT's latest enterprise value is 5,337.41 mil USD. CORT's TTM EBITDA according to its financial statements is -6.76 mil USD. Dividing these 2 quantities gives us the above CORT EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 5.5x - 8.2x | 7.0x |
| Forward P/E multiples | 10.1x - 17.3x | 12.0x |
| Fair Price | 0.67 - 8.88 | 3.53 |
| Upside | -98.7% - -82.6% | -93.1% |
| Date | EV/EBITDA |
| 2026-05-08 | -806.79 |
| 2026-05-07 | -787.43 |
| 2026-05-06 | -804.74 |
| 2026-05-05 | -791.84 |
| 2026-05-04 | -796.09 |
| 2026-05-01 | -793.25 |
| 2026-04-30 | -716.13 |
| 2026-04-29 | -717.23 |
| 2026-04-28 | -717.70 |
| 2026-04-27 | -711.41 |
| 2026-04-24 | -708.89 |
| 2026-04-23 | -693.46 |
| 2026-04-22 | -716.92 |
| 2026-04-21 | -693.78 |
| 2026-04-20 | -713.30 |
| 2026-04-17 | -710.46 |
| 2026-04-16 | -675.83 |
| 2026-04-15 | -674.89 |
| 2026-04-14 | -671.43 |
| 2026-04-13 | -665.45 |
| 2026-04-10 | -643.57 |
| 2026-04-09 | -648.92 |
| 2026-04-08 | -642.94 |
| 2026-04-07 | -640.10 |
| 2026-04-06 | -626.88 |
| 2026-04-02 | -652.70 |
| 2026-04-01 | -644.67 |
| 2026-03-31 | -618.38 |
| 2026-03-30 | -583.91 |
| 2026-03-27 | -575.73 |
| 2026-03-26 | -590.37 |
| 2026-03-25 | -620.90 |
| 2026-03-24 | -516.23 |
| 2026-03-23 | -513.24 |
| 2026-03-20 | -529.14 |
| 2026-03-19 | -520.32 |
| 2026-03-18 | -508.05 |
| 2026-03-17 | -511.35 |
| 2026-03-16 | -490.42 |
| 2026-03-13 | -489.95 |
| 2026-03-12 | -493.72 |
| 2026-03-11 | -514.97 |
| 2026-03-10 | -511.82 |
| 2026-03-09 | -518.91 |
| 2026-03-06 | -517.02 |
| 2026-03-05 | -519.69 |
| 2026-03-04 | -545.67 |
| 2026-03-03 | -539.21 |
| 2026-03-02 | -550.07 |
| 2026-02-27 | -545.82 |